Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein

Respiratory syncytial virus (RSV) causes severe lower respiratory tract illness in infants and young children. The significant morbidity and mortality rates associated with RSV infection make an effective RSV vaccine development a priority. Two neutralising antibody binding sites, Ø and II, located...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaberolansar, Noushin, Chappell, Keith J., Watterson, Daniel, Bermingham, Imogen M., Toth, Istvan, Young, Paul R., Skwarczynski, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593926/
https://www.ncbi.nlm.nih.gov/pubmed/28894111
http://dx.doi.org/10.1038/s41598-017-10415-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593926/
https://www.ncbi.nlm.nih.gov/pubmed/28894111
http://dx.doi.org/10.1038/s41598-017-10415-w

Ejemplares similares